{
    "title": "111_hr2134",
    "content": "The Act may be cited as the \"Western Hemisphere Drug Policy Commission Act of 2009\". Congress finds that drug use in the United States is significant, with millions of users of marijuana, cocaine, methamphetamine, and heroin. The majority of cocaine and heroin in the U.S. originates from Andean countries and Colombia and Mexico, respectively. The cultivation and trafficking of these drugs in these countries lead to violence, instability, and corruption. Additionally, drug trafficking in transit countries poses a threat to law enforcement, political institutions, citizen security, and U.S. interests. Trafficking is a major concern for organized criminals, threatening law enforcement, political institutions, and citizen security. Drug-related violence is increasing in Mexico and along the US-Mexico border, with a significant number of deaths reported. Organized criminal networks in Mexico traffic women and girls into the US for sexual exploitation. Extremist groups in the Western Hemisphere use drug trafficking to fund terrorist activities. The US has provided significant counternarcotics assistance to Latin America and the Caribbean. The Western Hemisphere Drug Policy Commission is established to review and evaluate US policies on illicit drug supply reduction and interdiction, focusing on international drug policies in the Western Hemisphere. The Commission will identify options to improve existing counternarcotics policies. The Commission will review US policies on illicit drug supply reduction, interdiction, and demand reduction, focusing on international drug control policies in the Western Hemisphere. Key topics include assessing drug interdiction efforts, economic development alternatives, technology deployment against drug cartels, and efforts to curb trafficking of chemical precursors. The Commission will assess the United States drug certification process, population's demand for illicit drugs, drug prevention and treatment programs, and recommendations to improve policies on reducing drug supply and demand. The Commission will review US drug policies, assess indicators of success, and consult with various stakeholders in the Western Hemisphere to improve drug control efforts. The Commission, consisting of leaders from international organizations and regions like the United States, Latin America, and the Caribbean, along with the Inter-American Drug Abuse Control Commission (CICAD), will submit a report to various committees and government officials within 12 months of its first meeting. The Commission, comprised of international leaders, will submit a report to government officials including the Secretary of State, Defense, and Health and Human Services, containing recommendations and findings for public availability. SEC. 6. MEMBERSHIP. The Commission consists of ten members appointed by various leaders, excluding current government officials. Each member serves for the Commission's duration, with vacancies filled promptly. Appointments must be made within 30 days, and an initial meeting to plan the review process must occur within 60 days of enactment. The Commission shall hold an initial meeting within 60 days to plan the review process and select a Chairperson. A quorum of six members is required for meetings. Members will receive travel expenses as per federal regulations. SEC. 7. POWERS. The Commission has the power to hold meetings, conduct hearings, and access necessary resources from various government agencies to carry out its duties. The General Services Administration will provide office space and administrative support for the Commission's activities. The General Services Administration will provide office space and administrative support for the Commission's activities. The Commission has the authority to use the United States mails and enter into contracts for necessary activities. SEC. 8. STAFF. The Commission shall have an Executive Director who can appoint necessary staff and pay them at a rate not exceeding level IV of the Executive Schedule. The Commission may also appoint additional personnel without following certain regulations, and the Executive Director can hire experts and consultants as needed. The Executive Director of the Commission can procure temporary services and detail government employees to assist in carrying out the duties of the Commission without affecting their civil service status or privileges. Authorization of $2,000,000 for the Western Hemisphere Drug Policy Commission without fiscal year limitation. Commission terminates 60 days after report submission to Congress."
}